ADI three-lens brief
Evidence-based stock research on ADI. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Outperforming SPY by 22.9pp over 30 days. · Trading at 96% of its 52-week range — near the top of the band.
- Trading at 96% of its 52-week range — near the top of the band.
- RSI at 77 — technically overbought.
- Outperforming SPY by 22.9pp over 30 days.
- P/E of 73 — priced for high growth; little margin of safety.
- Debt-to-equity of 25.8 — balance-sheet-heavy.
ADI closed at $399.57 (-1.07%) as of 2026-04-25. Market cap: $195.07B. P/E (trailing) 73.0. Positives: outperforming SPY by 22.9pp over 30 days.. Concerns: trading at 96% of its 52-week range — near the top of the band.; rSI at 77 — technically overbought.. Last quarter: Revenue $3.16B, net income $830.83M, free cash flow $4.14B. Watching for: 2026-05-20 earnings release (25 days out).
Why three lenses on ADI, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ADIacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ADI" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ADI brief"></iframe>